Literature DB >> 14580379

Augmented PLA2 activity in pre-eclamptic decidual tissue--a key player in the pathophysiology of 'acute atherosis' in pre-eclampsia?

A C Staff1, T Ranheim, B Halvorsen.   

Abstract

Decidual acute atherosis is associated with pre-eclampsia, but the underlying mechanism is still unclear. We have previously demonstrated elevated level of the oxidative stress marker 8-isoprostaglandin F(2 alpha)(8-isoprostane) and lipids in pre-eclamptic decidual tissue. Arachidonic acid (AA) in tissue phospholipids is a source for 8-isoprostane generation, and 8-isoprostane is liberated from tissue phospholipids by phospholipase A(2)(PLA(2)). The aims of this study were to explore whether AA content or PLA(2)expression in pre-eclamptic decidual tissue differed from controls. Decidua basalis tissues were obtained by vacuum aspiration at Caesarean delivery in pre-eclamptic and control pregnancies. We demonstrated a statistically significantly higher total PLA(2)activity in pre-eclamptic decidua compared to control tissue. On the other hand, no differences in AA content of tissue phospholipids or protein expression of secretory and cytosolic PLA(2)between pre-eclamptic and control decidual tissue were found. In conclusion, the elevated level of free 8-isoprostane in pre-eclamptic decidual tissue could be caused by augmented PLA(2)activity. We speculate that an elevated PLA(2)enzyme activity in pre-eclamptic decidual tissue could be of importance in the pathogenesis of 'acute atherosis', comparable to the atherogenesis in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580379     DOI: 10.1016/s0143-4004(03)00175-9

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

1.  Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

Authors:  Ghainsom D Kom; Edzard Schwedhelm; Renke Maas; Lydia Schneider; Ralf Benndorf; Rainer H Böger
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

2.  The immunophenotype of decidual macrophages in acute atherosis.

Authors:  Navleen Gill; Yaozhu Leng; Roberto Romero; Yi Xu; Bogdan Panaitescu; Derek Miller; Afrah Arif; Salma Mumuni; Faisal Qureshi; Chaur-Dong Hsu; Sonia S Hassan; Anne Cathrine Staff; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2019-03-04       Impact factor: 3.886

3.  A transcriptional profile of the decidua in preeclampsia.

Authors:  Mari Løset; Siv B Mundal; Matthew P Johnson; Mona H Fenstad; Katherine A Freed; Ingrid A Lian; Irina P Eide; Line Bjørge; John Blangero; Eric K Moses; Rigmor Austgulen
Journal:  Am J Obstet Gynecol       Date:  2011-01       Impact factor: 8.661

4.  Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies.

Authors:  S Zhao; Y Gu; D F Lewis; Y Wang
Journal:  Placenta       Date:  2007-10-22       Impact factor: 3.481

5.  Inhibitory Effect of the Punica granatum Fruit Extract on Angiotensin-II Type I Receptor and Thromboxane B2 in Endothelial Cells Induced by Plasma from Preeclamptic Patients.

Authors:  Widya Kusumawati; Kusnarman Keman; Setyawati Soeharto
Journal:  Adv Prev Med       Date:  2016-02-18

Review 6.  Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health.

Authors:  Daniel Pitz Jacobsen; Heidi Elisabeth Fjeldstad; Guro Mørk Johnsen; Ingrid Knutsdotter Fosheim; Kjartan Moe; Patji Alnæs-Katjavivi; Ralf Dechend; Meryam Sugulle; Anne Cathrine Staff
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

7.  Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.

Authors:  Rahana Abd Rahman; Padma Murthi; Harmeet Singh; Seshini Gurungsinghe; Bryan Leaw; Joanne C Mockler; Rebecca Lim; Euan M Wallace
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.